Cytosorbents (CTSO) Operating Income (2011 - 2026)
Cytosorbents (CTSO) posted Operating Income of -$3.0 million for Q1 2026, up 30.58% on a QoQ basis from -$4.4 million in Q4 2025, and up 21.71% year-over-year from -$2.5 million in Q1 2025.
Cytosorbents (CTSO) Operating Income (2011 - 2026) Analysis & Trends
Cytosorbents' Operating Income history runs 16 years deep, the most recent figure standing at -$3.0 million for Q1 2026.
- Quarterly Operating Income rose 21.71% year-over-year to -$3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$13.9 million (up 11.33% YoY) and the FY2025 annual result came in at -$14.7 million, up 10.35% from the prior year.
- Operating Income was -$3.0 million for Q1 2026 at Cytosorbents, up from -$4.4 million in the prior quarter.
- Across five years, Operating Income topped out at -$2.9 million in Q3 2025 and bottomed at -$9.4 million in Q4 2023.
- A 5-year average of -$5.7 million and a median of -$4.8 million in 2024 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income plunged 173.16% — and 2024, when it jumped 63.91%.
- Cytosorbents' Operating Income stood at -$6.4 million in 2022, then sank by 48.01% to -$9.4 million in 2023, then soared by 63.91% to -$3.4 million in 2024, then decreased by 29.16% to -$4.4 million in 2025, then soared by 30.58% to -$3.0 million in 2026.
- Business Quant data shows CTSO's Operating Income at -$3.0 million in Q1 2026, -$4.4 million in Q4 2025, and -$2.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | -3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.04 Mn |
| Dec 31, 2025 | -4.39 Mn |
| Sep 30, 2025 | -2.86 Mn |
| Jun 30, 2025 | -3.62 Mn |
| Mar 31, 2025 | -3.89 Mn |
| Dec 31, 2024 | -3.40 Mn |
| Sep 30, 2024 | -4.83 Mn |
| Jun 30, 2024 | -3.57 Mn |
| Mar 31, 2024 | -4.66 Mn |
| Dec 31, 2023 | -9.41 Mn |
| Sep 30, 2023 | -7.35 Mn |
| Jun 30, 2023 | -6.56 Mn |
| Mar 31, 2023 | -7.89 Mn |
| Dec 31, 2022 | -6.36 Mn |
| Sep 30, 2022 | -9.02 Mn |
| Jun 30, 2022 | -8.36 Mn |
| Mar 31, 2022 | -7.79 Mn |
| Dec 31, 2021 | -9.56 Mn |
| Sep 30, 2021 | -5.41 Mn |
| Jun 30, 2021 | -4.92 Mn |